[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

Deng,Qingfu; Luo,Li; Quan,Zhen; Liu,Nanjing; Du,Zhongbo; Sun,Wei; Luo,Chunli; Wu,Xiaohou

doi:10.3892/mmr.2022.12746

July-2022 Volume 26 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2022 Volume 26 Issue 1

Full Size Image

Correction Open Access

[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

Authors:
- Qingfu Deng
- Li Luo
- Zhen Quan
- Nanjing Liu
- Zhongbo Du
- Wei Sun
- Chunli Luo
- Xiaohou Wu
View Affiliations / Copyright

Affiliations: Department of Urology, First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, P.R. China, Key Laboratory of Diagnostics Medicine Designated by The Ministry of Education, Chongqing Medical University, Chongqing 400042, P.R. China

Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Article Number: 230
|
Published online on: May 23, 2022

https://doi.org/10.3892/mmr.2022.12746
Expand metrics +

Article

Mol Med Rep 19: [Related article:] 2115–2124, 2019; DOI: 10.3892/mmr.2019.9841

Following the publication of the above article, an interested reader drew to the authors’ attention that the western blotting data shown in Figs. 2F and 5E were strikingly similar, even though they were intended to show the results from differently performed experiments; furthermore, the migration assay images shown for the 24 h ‘Blank’ and ‘Vector’ experiments in Fig. 3C were apparently the same.

Figure 5.

Differences in AR subcellular localization associated with si-Ran. (A) Relative mRNA expression levels of Ran was determined using reverse transcription-quantitative polymerase chain reaction after Ran was silenced by si-Ran in the LNCaP cells. (B and C) Ran protein expression was analysed using western blotting after Ran had been silenced by si-Ran in the LNCaP cells. (D) ELISA analysis of PSA was performed in the culture medium supernatant of the different groups at 12–48 h. Subcellular localization of AR protein in the LNCaP cells treated with si-Ran in the presence or absence of (E) ad-HepaCAM and (F) ad-HepaCAM-mt was analysed using western blotting. The data are presented as the mean ± standard deviation. *P<0.05, **P<0.01 and ***P<0.001. Ad, adenovirus; AR, androgen receptor; HepaCAM, hepatocyte cell adhesion molecule; mt, mutant; NC, negative control; PSA, prostate specific antigen; si, small interference.

Figure 3.

HepaCAM overexpression inhibits invasion and migration of LNCaP cells. (A and B) Wound healing assay of the LNCaP cells with different treatments. (C and D) Migrated LNCaP cells, as measured by Matrigel migration assay. (E and F) Expression levels of E-cadherin, N-cadherin, and Snail, as analysed by western blotting. The data are presented as the mean ± standard deviation. Magnification, ×200. *P<0.05, **P<0.01, ***P<0.001. Ad, adenovirus; HepaCAM, hepatocyte cell adhesion molecule; mt, mutant..

The authors have consulted their original data, and realized that the errors in the presentation of these figures arose inadvertently as a consequence of selecting the wrong images for the 24 h ‘Blank’ experiement in Fig. 3C and the western blot for the AR / Nucleus experiment in Fig. 5E. The revised versions of Figs. 3 and 5 are shown on the next two pages. All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret that these errors were included in the paper, and also apologize to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain

This article is mentioned in:

Article

Figure 5.

Figure 3.

Related Articles